[Skip to content]

Private Healthcare UK
Search our Site

This website is certified by Health On the Net Foundation. Click to verify.
This site complies with the HONcode standard for trustworthy health information:
verify here.

Advertisement
.

HCA wins two major Laing and Buisson awards for healthcare outcomes and medical practice

HCA International

HCA International, which owns London’s six leading private hospitals, has won two ‘firsts’ at the prestigious Laing and Buisson annual Independent Healthcare Awards.

 

Rosemary Hittinger, Group Director of Clinical Performance and Governance, collected the top prize for the most comprehensive outcome programme in the independent sector and London Bridge Hospital Chief Perfusionist, Alan Rayner and Consultant Cardiologist Dr Cliff Bucknall won the medical practice award for their work on the prevention of blood clots in cardiac patients.

 

HCA had 11 finalists in 8 categories of award, more than any other healthcare provider.

 

HCA’s hospitals was a pioneer in releasing outcome data and over recent years it has developed the most comprehensive Outcomes Programme in the acute sector.  With healthcare providers coming under increasing scrutiny from patients and their families, regulators and politicians alike, the need for transparency and like for like benchmarking has grown apace. 

 

Rosemary Hittinger said she was delighted that the group’s work had been recognised.  “We have invested considerable resource and effort in recent years to develop the most comprehensive of comparable and benchmarked outcomes for patients, relatives, regulators and politicians alike,” she said.

 

“We will continue to build on our experience with other independent providers with the Hellenic Project,” she said.  Rosemary Hittinger is currently leading the group’s Quality Programme.

 

The Medical Practice Award went to Alan Rayner and Dr Cliff Bucknall at London Bridge Hospital.  They have introduced a new combined procedure to identify patients who do not respond to Aspirin and Clopidogrel (Plavix) given to prevent excessive clot formation. Linking platelet function (Multiplate®) and a rapid ‘point of care’ genetic test (Spartan Rx®) has enabled an individualised approach to medication in those patients with a predisposition towards life threatening blood clotting, thus preventing them suffering any ill effects during or after an operation.

 

“We are thrilled by this award.  It’s more recognition that pioneering work is increasingly to be found in the private sector and in our case, the systems we have combined  enable cardiologists and cardiac surgeons to prescribe medication with evidence that it is effective – very quickly -  for those patients who are shown to be at risk because they do not respond,” he said.

 

Michael Neeb, President and Chief Executive Officer of HCA International, said, “HCA is committed to providing the highest quality patient care in a safe, clean, compassionate environment, and we are delighted to have once again been recognised by Laing and Buisson in winning the national awards for Healthcare Outcomes and Medical practice.  HCA has now won more L+B awards than any other provider.”

Private hospital news : 4 October 2011

Get a Quote

Private hospital companies

Get a quote now

Typical Costs

Private hospital companies

View typical costs